{"raw_mentions": "Here are the extracted sentences with concrete data points that meet the specified criteria:\n\n\nIn parallel, a temporal control was performed to rule out any artifacts on the measured contraction, where was added only the vehicle (ultrapure water \nMilli\n Q \u00ae) instead of the substance to be tested, before and after incubation for 1 hour of the LDT's at 10 or 50 nM.\nIt was carried out cumulative curves to \nphenylephrine\n (10-8 - 10-3 M) in the presence of 1 \u00b5M \npropranolol\n (\u03b2-adrenoceptor blocker receptors) before and after incubation for 1 hour of the LDT's 3, 10 or 100 50 nM.\nIn the pharmacological screening process, the initial concentration of the used LDT's was 50 nM, which is considered as cut concentration, i.e., substances that have no effect at this concentration would not investigated in this test.\nThe substances that were in effect, were then tested at lower concentrations (10 or 2 nM) (Table 2).\nThen the preparation was washed and allowed to stand for 1 hour in order to recover the tissue, Then it was performed cumulative curves to \nphenylephrine\n (10-9 to 10-5 M) in the presence of \npropranolol\n 1 \u00b5M (\u03b2-adrenoceptor blocker receptors) before and after incubation for 1 hour of the LDT's at 10 or 50 nM."}
{"final_json": [{"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "50", "unit": "nM"}, {"molecule_name": "phenylephrine", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10-8", "unit": "M"}, {"molecule_name": "phenylephrine", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10-3", "unit": "M"}, {"molecule_name": "propranolol", "protein_target_name": "\u03b2-adrenoceptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "1", "unit": "\u00b5M"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "3", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "100", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "50", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "2", "unit": "nM"}, {"molecule_name": "phenylephrine", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10-9", "unit": "M"}, {"molecule_name": "phenylephrine", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10-5", "unit": "M"}, {"molecule_name": "propranolol", "protein_target_name": "\u03b2-adrenoceptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "1", "unit": "\u00b5M"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "50", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences with concrete data points that meet the specified criteria:\n\n\nFor competition assays, test tubes containing 350 \u00b5L of intermediate solution ([3H]-prazosin 0.16 nM, 1.6 mM \nEDTA\n, 50 mM \nTris\n (pH 7.4 at 25\u00b0C)) it was added the 50 \u00b5L of different concentrations of LDT's (end concentration 10-9 - 10-4 M) or 50 \u00b5L of water (solvent for dilution of LDT's) for the determination of total binding or 50 \u00b5L nonradioactive \nprazosin\n at 10 \u00b5M (end 1 \u00b5M) to the determination of nonspecific binding, and 200 \u00b5g of membrane preparations of rabbit liver (\u03b11A) contained in 50 \u00b5L suspension completing end volume of 500 \u00b5L.\nBinding of [3H]-prazosin to \u03b11B adrenoceptorsBinding assays were standardized for \u03b11B adrenoceptors in the same way adrenoceptor binding assays for \u03b11A according to the literature, i.e. saturation and competition assays were performed on membrane preparations from rat liver, in this case using 150 g protein per tube contained 50 Ml suspension, in addition to various concentrations of LDT's (10-9 - 10-6 M)"}
{"final_json": [{"molecule_name": "[3H]-prazosin", "protein_target_name": "\u03b11A adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "0.16", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "\u03b11A adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10-9 - 10-4", "unit": "M"}, {"molecule_name": "prazosin", "protein_target_name": "\u03b11A adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10", "unit": "\u00b5M"}, {"molecule_name": "[3H]-prazosin", "protein_target_name": "\u03b11B adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "LDT's", "protein_target_name": "\u03b11B adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": null, "value": "10-9 - 10-6", "unit": "M"}]}
{"raw_mentions": "Here are the extracted sentences with bioactivity metrics (IC50, Ki, Kd, EC50) along with specific numeric values and units:\n\n\nThe values of Kd and Bmax were 2.05 \u00b1 0.28 nM and 124 \u00b1 7 fmol / mg protein (n = 1), respectively.\nThe values of Kd and Bmax were 0.7 \u00b1 0.1 nM and 125 \u00b1 42 fmol / mg protein, respectively (Neves et al., Bioorg Med. Chem. 18 (5): 1925-1935, 2010).\nKd values of [3H]-prazosin to \u03b11A adrenoceptors were 0.46 nM and 56.5 nM for sites with high and low affinities, respectively (n = 3), and \u03b11B adrenoceptors the Kd value was 0,34 nM (n = 3).\nThe Kd value was used to calculate Ki of LDT's using the Cheng-Prusoff equation, with Kd = 1.77 \u00b1 0.07 nM for 5-HT2A receptors.\nKi values were calculated using the Cheng-Prusoff equation, with Kd = 0.7 nM \u00b1 0.1 nM for 5-HT1A receptors.\nTable 3: pharmacological parameters of the LDT's (2-6 and 8) in the \u03b11A-adrenoceptors, with Ki values in nM.\nTable 4: Pharmacological Parameters of the LDT's (2-6, 8) \u03b11B adrenoceptor, with Ki values in nM.\nTable 5: Pharmacological parameters of LDT' s (62-70 and 39) in \u03b11A and \u03b11B adrenoceptor, with Ki values in nM.\nTable 6: Pharmacological Parameters of the LDT's (65-68) in \u03b12A receptors, with Ki values in \u00b5M.\nTable 7: Pharmacologicalparameters ofLDT's (2-6, 8, 245) for 5-HT1A receptors, with Ki values in nM.\nTable 8: Pharmacological Parameters LDT' s (62-70, 39) in the 5-HT1A, with Ki values in nM.\nTable 9. intrinsic activity estimative of LDT 65-68 in 5-HT1A receptors, with Ki values in nM.\nTable 10: Pharmacological Parameters LDT's (2-6 and 8) with 5-HT2A receptors, with Ki values in M.\nTable 11: pharmacological parameters of the LDT's (62-70, 39) on 5-HT2A receptors, with Ki values in nM.\nTable 12: Pharmacological parameters of the LDT's on \u03b12A receptors, with Ki values in \u00b5M.\nTable 13. Intrinsic activity estimate of LDT's on 5-HT1A receptors, with Ki values in nM.\nTable 14: Pharmacological Parameters LDT's on muscarinic receptors, with Ki values in \u00b5M.\nTable 15: pharmacological parameters of LDT's on D2 dopaminergic receptors, with Ki values in \u00b5M."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "2.05 \u00b1 0.28", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "0.7 \u00b1 0.1", "unit": "nM"}, {"molecule_name": "[3H]-prazosin", "protein_target_name": "\u03b11A adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "0.46", "unit": "nM"}, {"molecule_name": "[3H]-prazosin", "protein_target_name": "\u03b11A adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "56.5", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "\u03b11B adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "0,34", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "5-HT2A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "1.77 \u00b1 0.07", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "5-HT1A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Kd", "value": "0.7", "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "\u03b11A-adrenoceptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "\u03b11B adrenoceptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "\u03b11A and \u03b11B adrenoceptor", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "\u03b12A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "\u00b5M"}, {"molecule_name": "LDT's", "protein_target_name": "5-HT1A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "5-HT1A", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT 65-68", "protein_target_name": "5-HT1A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "5-HT2A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "M"}, {"molecule_name": "LDT's", "protein_target_name": "5-HT2A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "\u03b12A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "\u00b5M"}, {"molecule_name": "LDT's", "protein_target_name": "5-HT1A receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "nM"}, {"molecule_name": "LDT's", "protein_target_name": "muscarinic receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "\u00b5M"}, {"molecule_name": "LDT's", "protein_target_name": "D2 dopaminergic receptors", "protein_uniprot_id": null, "protein_seq_id": null, "binding_metric": "Ki", "value": null, "unit": "\u00b5M"}]}
